FilingSEC EDGAR8-K
bioAffinity Technologies Completes $4 Million Financing and Suspends ATM Agreement
· SEC accepted
StageCompleted
Filing content
bioAffinity Technologies closed a $4 million registered direct offering and concurrent private placement of common stock and warrants, and suspended its existing at-the-market sales agreement.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…